Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...

Johnson & Johnson (NYSE: JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson ...

Johnson & Johnson is a globally diversified healthcare conglomerate with two main operating segments. The Innovative Medicine ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

These four very safe dividend stocks from the Goldman Sachs Conviction list may be good ideas for what could be a volatile ...

Explore market-impacting Trump administration moves, from drug pricing reforms targeting pharma giants to Swiss tariff hikes.

JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.

Shares of European pharmaceutical companies sold off on Friday after President Donald Trump issued letters to 17 companies, ...

President Donald Trump has sent letters to the CEOs of 17 pharmaceutical companies demanding action to address high prescription drug costs in the United States, the White House announced Thursday.

The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.

Investors say that J&J knowingly inflated its stock value by hiding information about asbestos contamination of its talc ...